Clinical trial
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)
NCT00156117 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00156117 |
|---|---|
| Title | Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) |
| Official title | A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Olanzapine Positive Control in Subjects With an Acute Exacerbation of Schizophrenia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | asenapine, Placebo, olanzapine |
| Enrollment | 417 |
| Start date | May 12, 2005 |
| Primary completion | Apr 28, 2006 |
| Completion | May 30, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: